Brief: Matinas Biopharma Announces Pricing Of $8 Mln Public Offering

Matinas BioPharma Holdings

19/06/2018 13:09

June 19 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA ANNOUNCES PRICING OF $8.0 MILLION PUBLIC
OFFERING
    * MATINAS BIOPHARMA - PRICING OF PUBLIC OFFERING OF ITS
SERIES B
CONVERTIBLE PREFERRED STOCK WHICH IS CONVERTIBLE INTO SHARES OF
COMMON STOCK AT $0.50/SHARE

Source text for Eikon:  ID:nGNX2cyVrS 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))